February 22, 2012 7:18 AM
Jon L. Gelman is reviewing potential hip replacement lawsuits involving individuals who were implanted with the DePuy Orthopaedics ASR™ XL Acetabular Hip Replacement System or ASR™ Hip Resurfacing System and experienced pain or other symptoms that led to a second hip replacement surgery. Both devices are manufactured by DePuy Orthopaedics, a division of Johnson & Johnson Services, Inc. The ASR XL Acetabular System is a total hip replacement system involving the cup portion of a replacement hip, and the ASR Hip Resurfacing System is a partial hip replacement that involves placing a metal cap on the ball of the femur or hip bone.
If you or someone you know has experienced pain or required revision surgery following the implantation of either the ASR XL Acetabular Hip Replacement System or ASR Hip Resurfacing System, please contact Jon Gelman by e-mail or call + 1 973-696-7900 to discuss your potential hip replacement lawsuit.
Hip Replacement Side Effects
Side effects that have been linked to the ASR hip replacement devices include:
- Fractured hip bone resulting from implant failure
- Loosening of the implant
- Hip, thigh or groin pain
- pain when walking, standing or carrying weighted objects
If you experienced serious hip replacement side effects or required additional surgery after being implanted with a DePuy Orthopaedics ASR hip replacement system, you may have a potential hip replacement lawsuit.
ASR Hip Replacement Device Recall Information
The ASR systems belong to a class of large diameter, monoblock hip replacement and resurfacing devices frequently chosen by surgeons for use on younger patients who might receive greater benefit from a device offering more stability, lessening the chances of post-surgery dislocation. Introduced in 2003, the ASR Hip Resurfacing System is approved for use only outside of the United States. In 2004, the ASR XL Acetabular System was introduced globally and remains one of the few such devices on the worldwide market.
On Thursday, August 26, 2010, DePuy issued a voluntary recall of the two ASR hip replacement systems, stating that “This recall means additional testing and treatment may be necessary to ensure the hip is functioning well. In some cases, patients may need additional surgery.”
The recall decision was prompted by unpublished 2010 data from the National Joint Registry of England and Wales showing that more patients than expected who received implants with one of the devices experienced pain and other adverse side effects that led to a second hip replacement surgery. In the study, there was a five-year revision rate of approximately 12% for the ASR Hip Resurfacing System and 13% for the ASR XL Acetabular System. Few of these systems remain on the market as DePuy decided to discontinue sales in 2009 due to a decrease in demand and the emergence of new products, but the company is advising patients who have been implanted with an ASR device to visit their doctors for an evaluation and future monitoring.
Read detailed information from DePuy about the ASR Hip System recall.
Related Articles:
Document: 2009 e-mail on Defective Hip Device 2/21/12
Hip Maker Discussed Failures 2/21/12
Hip Implant Complaints Surge, Even as Dangers Are Studied nytimes.com 8/22/11
FDA Orders Surveliance of Hip Implants 5.16.11